Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology
- 31 March 1996
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (3) , 299-307
- https://doi.org/10.1016/s0002-9343(97)89488-0
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantationHematological Oncology, 2007
- Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphomaBlood, 1994
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1993
- What's the deal with follicular lymphomas?Journal of Clinical Oncology, 1993
- Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's LymphomaNew England Journal of Medicine, 1992
- Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.Journal of Clinical Oncology, 1992
- Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantationBlood, 1991
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982